Snoring is often dismissed as a social nuisance, but emerging clinical evidence suggests it may play a direct role in the progression of obstructive sleep apnea (OSA). While traditionally viewed …
Tag:
obstructive sleep apnea
-
-
The Impact of Obesity Medications on Physical Function: What New Data Shows Recent research indicates that obesity management medications may improve self-reported physical function in patients, while providing modest gains …
-
Recent research identifies a link between gut microbiome composition and obstructive sleep apnea (OSA) severity, specifically regarding how microbially modified bile acids affect metabolic and respiratory health. Studies indicate that …
-
Health
Untreated OSA Patients and Healthy Sleepers: High-Resolution MRI Analysis of Subcortical Brain Changes
Understanding the Impact of Obstructive Sleep Apnea on Brain Structure: A Neuroimaging Perspective Obstructive sleep apnea (OSA), a common sleep disorder characterized by repeated interruptions in breathing during sleep, affects …
-
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Key Risk Factors and Clinical Insights Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease (NAFLD), is the most common …
-
Central Sleep Apnea vs. Obstructive Sleep Apnea: Understanding the Key Differences If you’ve ever woken up gasping for air or spent your day feeling like your brain is stuck in …
-
GLP-1 Agonists: A New Frontier in Sleep Apnea Treatment Obstructive sleep apnea (OSA) is a common yet often underdiagnosed condition characterized by repeated interruptions in breathing during sleep. Traditionally, treatment …
-
GLP-1 Weight Loss Drugs: Many Patients Restart or Switch Therapies After Stopping A recent study indicates that many individuals who discontinue glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight …
-
GLP-1 Receptor Agonists: A New Era in Metabolic and Cardiovascular Health A sweeping review published in The Lancet reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, …
-
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in obstructive sleep apnea. Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes …